Freda is an independent commercial stategy and diligence consultant for biotech, life sciences, pharmaceutical, med tech, health tech, digital therapeutics and diagnostic companies. She has 20 years of experience in commercial strategy and has held senior leadership positions at Pfizer, Novartis, BMS and Merck for more than 25 brands across Oncology, Hematology, Rare Diseases, Women’s Health, Cardiovascular (ASCVD), Type 1 and Type 2 Diabetes, End Stage Renal Disease (ESRD), Immunology, Gastroenterology, Infectious Disease, Respiratory, CNS, Neuroscience and Mental Health.

• Serve as Chief Commercial Officer preparing biotech startups for initial commercialization (including pipeline indications and age extensions), partnerships, licensing or M&A

• Expertise in scaling biotech startups with operational excellence and thoughtful financial judgement

• Board of Directors (BOD) meeting and presentation development

• Financial acumen: Pre and post investment diligence, P&L ownership, OPEX, sales forecasting and demand management for private equity and venture capital firms

• Geographic commercial excellence: US, regional, global and emerging markets experience

• Experience in genomic sequencing, companion diagnostics, predictive biomarkers, and microbiome diagnostics

• Expertise in Transplant, BMT, ALLO and AUTO HSCT, advanced myeloablation, cell and gene therapy technology

• Also support scientific advancement for Non THC Cannabinoid-based therapeutic treatments